Last reviewed · How we verify
Urokinase and Dornase alfa — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Urokinase and Dornase alfa (Urokinase and Dornase alfa) — Azienda Ospedaliera di Padova.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Urokinase and Dornase alfa TARGET | Urokinase and Dornase alfa | Azienda Ospedaliera di Padova | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Urokinase and Dornase alfa CI watch — RSS
- Urokinase and Dornase alfa CI watch — Atom
- Urokinase and Dornase alfa CI watch — JSON
- Urokinase and Dornase alfa alone — RSS
Cite this brief
Drug Landscape (2026). Urokinase and Dornase alfa — Competitive Intelligence Brief. https://druglandscape.com/ci/urokinase-and-dornase-alfa. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab